Waisser K - Search Results

1

Prediction of retention characteristics of heterocyclic compounds.

Nesměrák K, Toropov AA, Toropova AP, Yildiz I, Yalcin I, Brozikova M, Klimešová V, Waisser K. Nesměrák K, et al. Among authors: waisser k. Anal Bioanal Chem. 2015 Dec;407(30):9185-9. doi: 10.1007/s00216-015-9067-6. Epub 2015 Oct 1. Anal Bioanal Chem. 2015. PMID: 26427498

2

SMILES-based quantitative structure-property relationships for half-wave potential of N-benzylsalicylthioamides.

Nesmerak K, Toropov AA, Toropova AP, Kohoutova P, Waisser K. Nesmerak K, et al. Among authors: waisser k. Eur J Med Chem. 2013 Sep;67:111-4. doi: 10.1016/j.ejmech.2013.05.031. Epub 2013 Jun 18. Eur J Med Chem. 2013. PMID: 23850571

3

New benzimidazole derivatives as antimycobacterial agents.

Klimesová V, Kocí J, Waisser K, Kaustová J. Klimesová V, et al. Among authors: waisser k. Farmaco. 2002 Apr;57(4):259-65. doi: 10.1016/s0014-827x(02)01218-1. Farmaco. 2002. PMID: 11989805

4

Heterocyclic benzazole derivatives with antimycobacterial in vitro activity.

Kocí J, Klimesová V, Waisser K, Kaustová J, Dahse HM, Möllmann U. Kocí J, et al. Among authors: waisser k. Bioorg Med Chem Lett. 2002 Nov 18;12(22):3275-8. doi: 10.1016/s0960-894x(02)00697-2. Bioorg Med Chem Lett. 2002. PMID: 12392731

5

Antimycobacterial N-pyridinylsalicylamides, isosters of salicylamides.

Waisser K, Drazková K, Kunes J, Klimesová V, Kaustová J. Waisser K, et al. Farmaco. 2004 Aug;59(8):615-25. doi: 10.1016/j.farmac.2004.02.003. Farmaco. 2004. PMID: 15262531

6

Heterocyclic isosters of antimycobacterial salicylanilides.

Matyk J, Waisser K, Drazková K, Kunes J, Klimesová V, Palát K Jr, Kaustová J. Matyk J, et al. Among authors: waisser k. Farmaco. 2005 May;60(5):399-408. doi: 10.1016/j.farmac.2005.02.002. Epub 2005 Apr 12. Farmaco. 2005. PMID: 15910812 Review.

7

Preparation and in vitro evaluation of benzylsulfanyl benzoxazole derivatives as potential antituberculosis agents.

Klimesová V, Kocí J, Waisser K, Kaustová J, Möllmann U. Klimesová V, et al. Among authors: waisser k. Eur J Med Chem. 2009 May;44(5):2286-93. doi: 10.1016/j.ejmech.2008.06.027. Epub 2008 Jul 5. Eur J Med Chem. 2009. PMID: 18694614

8

3-Benzyl-2H-1,3-benzoxazine-2,4(3H)-diones, a new group of antimycobacterial compounds against potentially pathogenic strains.

Waisser K, Perina M, Kunes J, Klimesová V, Kaustová J. Waisser K, et al. Farmaco. 2003 Nov;58(11):1137-49. doi: 10.1016/j.farmac.2003.07.004. Farmaco. 2003. PMID: 14572865

9

Synthesis and antimycobacterial activity of pyridylmethylsulfanyl and naphthylmethylsulfanyl derivatives of benzazoles, 1, 2, 4-triazole, and pyridine-2-carbothioamide/-2-carbonitrile.

Zahajská L, Klimesová V, Kocí J, Waisser K, Kaustová J. Zahajská L, et al. Among authors: waisser k. Arch Pharm (Weinheim). 2004 Oct;337(10):549-55. doi: 10.1002/ardp.200400899. Arch Pharm (Weinheim). 2004. PMID: 15476287

10

QSPR modeling of the half-wave potentials of benzoxazines by optimal descriptors calculated with the SMILES.

Toropov A, Nesmerak K, Raska I Jr, Waisser K, Palat K. Toropov A, et al. Among authors: waisser k. Comput Biol Chem. 2006 Dec;30(6):434-7. doi: 10.1016/j.compbiolchem.2006.09.003. Epub 2006 Nov 7. Comput Biol Chem. 2006. PMID: 17092778

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

126 results

Search Page